Universitaetsklinikum Schleswig-Holstein AöR

Hematology and Paediatric Oncology

Research activity includes multiple myeloma and acute lymphoblastic leukemia in children and adolescents, with interest in treatment response, disease control, and risk-adapted therapy.

  • Multiple myeloma
  • acute lymphoblastic leukemia
  • immunotherapy
  • minimal residual disease

The sponsor also supports work in treatment stratification and maintenance of remission in blood cancers.

Gastroenterology and Hepatobiliary Disease

Clinical research spans ulcerative colitis, primary sclerosing cholangitis, intrahepatic cholangiocarcinoma, and post-transplant care related to liver transplantation.

  • ulcerative colitis
  • primary sclerosing cholangitis
  • intrahepatic cholangiocarcinoma
  • liver transplantation

Additional interests include postoperative complications after pancreatic surgery and therapy-related outcomes in digestive system disorders.

Autoimmune and Inflammatory Disorders

The sponsor funds studies in pemphigus vulgaris, mucous membrane pemphigoid, polymyositis, dermatomyositis, and related immune-mediated conditions.

  • pemphigus vulgaris
  • mucous membrane pemphigoid
  • polymyositis
  • dermatomyositis

Work in this area also covers immune modulation and inflammatory disease control across multiple organ systems.

Metabolic and Cardiovascular Medicine

Trials address arterial hypertension and prediabetes, with attention to cardiovascular and renal risk reduction as well as metabolic disease remission.

  • arterial hypertension
  • prediabetes
  • cardiovascular risk
  • renal outcomes

These studies reflect interest in chronic disease management and prevention of end-organ complications.

Neurology, Neonatology, and Palliative Care

Research includes myoclonic-astatic epilepsy, respiratory distress syndrome in preterm infants, and symptom-focused care in palliative oncology.

  • myoclonic-astatic epilepsy
  • respiratory distress syndrome
  • palliative oncology
  • quality of life

Studies also examine functional outcomes after transplantation and long-term symptom burden in complex clinical populations.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Low-Risk Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Study on Preoperative Treatment with Gemcitabine, Cisplatin, Durvalumab, and Tremelimumab for Patients with Intrahepatic Cholangiocarcinoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Study on Cognitive Function in Liver Transplant Patients Comparing Once-Daily and Twice-Daily Tacrolimus Formulations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany